β-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2083-2090

  Zhang, Hang ^a   Xu, Feng ^b   Xie, Tian ^a   Jin, Hongchuan ^b   Shi, Liyun ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

elemene; Apoptosis; Glioma; Survivin

Indexed keywords

BETA ELEMENE; CASPASE 3; CASPASE 7; CASPASE 9; HEPATITIS B VIRUS X PROTEIN; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOMA CELL; PRIORITY JOURNAL; PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BRAIN NEOPLASMS; CASPASE 3; CASPASE 7; CASPASE 9; CELL LINE, TUMOR; DOWN-REGULATION; GINGER; GLIOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; SESQUITERPENES;

EID: 84868118053     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2022     Document Type: Conference Paper

References (41)

1. Fisher JL, Schwartzbaum JA, Wrensch M and Wiemels JL: Epidemiology of brain tumors. Neurol Clin 25:867-890, vii, 2007. (Pubitemid 47603275)
2. Ohgaki H and Kleihues P: Epidemiology and etiology of gliomas. Acta Neuropathol 109:93-108, 2005. (Pubitemid 40287792)
3. Little M P, De Vathaire F, Shamsaldin A, et al: Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78:269-275, 1998. (Pubitemid 28445359)
4. Bondy ML, Wang LE, El-Zein R, et al: Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553-1557, 2001.
5. Wang G, Li X, Huang F, et al: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62:881-893, 2005. (Pubitemid 40655635)
6. Wang Y, Deng Y, Mao S, Jin S, Wang J and Bi D: Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN). Drug Dev Ind Pharm 31:769-778, 2005. (Pubitemid 41356193)
7. Li X, Wang G, Zhao J, et al: Antiproliferative effect of betaelemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62:894-904, 2005. (Pubitemid 40655636)
8. Xie CY, Yang W, Li M, et al: Cell apoptosis induced by delta-elemene in colorectal adenocarcinoma cells via a mitochondrial-mediated pathway. Yakugaku Zasshi 129:1403-1413, 2009.
9. Sasaki K, Tsuno NH, Sunami E, et al: Chloroquine potentiates the anti-cancer effect of 5-fuorouracil on colon cancer cells. BMC Cancer 10:370, 2010.
10. Mesri M, Wall NR, Li J, Kim RW and Altieri DC: Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 108:981-990, 2001. (Pubitemid 32946072)
11. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921, 1997. (Pubitemid 27353455)
12. Das A, Tan WL, Teo J and Smith DR: Expression of survivin in primary glioblastomas. J Cancer Res Clin Oncol 128:302-306, 2002. (Pubitemid 34569350)
13. Holcik M, Gibson H and Korneluk RG: XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6:253-261, 2001. (Pubitemid 32708519)
14. Holcik M and Korneluk RG: XIAP, the guardian angel. Nat Rev Mol Cell Biol 2:550-556, 2001. (Pubitemid 33673406)
15. Song Z, Yao X and Wu M: Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 278:23130-23140, 2003. (Pubitemid 36830379)
16. Liu T, Brouha B and Grossman D: Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 23:39-48, 2004. (Pubitemid 38142238)
17. Uren AG, Wong L, Pakusch M, et al: Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 10:1319-1328, 2000.
18. Fraser AG, James C, Evan GI and Hengartner MO: Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr Biol 9:292-301, 1999. (Pubitemid 29181835)
19. Speliotes EK, Uren A, Vaux D and Horvitz HR: The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol Cell 6:211-223, 2000.
20. Temme A, Rieger M, Reber F, et al: Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol Biol Cell 14:78-92, 2003. (Pubitemid 36106021)
21. Liston P, Young SS, Mackenzie AE and Korneluk RG: Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2:423-441, 1997. (Pubitemid 127508254)
22. Melegari M, Scaglioni PP and Wands JR: Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 72:1737-1743, 1998. (Pubitemid 28100722)
23. Marusawa H, Matsuzawa S, Welsh K, et al: HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22:2729-2740, 2003. (Pubitemid 36712369)
24. Paydas S, Tanriverdi K, Yavuz S, Disel U, Sahin B and Burgut R: Survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol 14:1045-1050, 2003. (Pubitemid 36950168)
25. Grossman D, Kim PJ, Blanc-Brude OP, et al: Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 108:991-999, 2001. (Pubitemid 32946073)
26. Shin S, Sung BJ, Cho YS, et al: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123, 2001. (Pubitemid 32108606)
27. Chandele A, Prasad V, Jagtap JC, Shukla R and Shastry PR: Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 6:29-40, 2004. (Pubitemid 38391947)
28. Li QQ, Wang G, Zhang M, Cuff CF, Huang L and Reed E: Beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22:161-170, 2009.
29. Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 264:127-134, 2008. (Pubitemid 351602131)
30. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281:1312-1316, 1998. (Pubitemid 28406817)
31. Ashkenazi A and Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260, 1999. (Pubitemid 29164042)
32. Li P, Nijhawan D, Budihardjo I, et al: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489, 1997. (Pubitemid 27508237)
33. Zou H, Li Y, Liu X and Wang X: An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549-11556, 1999.
34. Senderowicz AM: Cell cycle modulators for the treatment of lung malignancies. Clin Lung Cancer 5:158-168, 2003. (Pubitemid 38028805)
35. Swana HS, Grossman D, Anthony JN, Weiss RM and Altieri DC: Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453, 1999. (Pubitemid 29362524)
36. Okada E, Murai Y, Matsui K, et al: Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109-116, 2001. (Pubitemid 32121836)
37. Ito T, Shiraki K, Sugimoto K, et al: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085, 2000. (Pubitemid 30233232)
38. Kawasaki H, Toyoda M, Shinohara H, et al: Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026-2032, 2001. (Pubitemid 32476366)
39. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M and Altieri DC: Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-883, 1998. (Pubitemid 28121185)
40. Chakravarti A, Noll E, Black PM, et al: Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-1068, 2002. (Pubitemid 34141851)
41. Tamm I, Wang Y, Sausville E, et al: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320, 1998. (Pubitemid 28551107)